Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells
-
Add time:08/23/2019 Source:sciencedirect.com
Vascular inflammation plays a critical role in the pathogenesis of diabetic retinopathy. Recently, Interleukin-6 (IL-6) trans-signaling via soluble IL-6 receptor (sIL-6R) has emerged as a prominent regulator of inflammation in endothelial cells. This study was designed to test the hypothesis that selective inhibition of the IL-6 trans-signaling pathway will attenuate inflammation and subsequent barrier disruption in retinal endothelial cells. Human retinal endothelial cells (HRECs) were exposed to IL-6 and sIL-6R to induce IL-6 trans-signaling and the commercially available compound sgp130Fc (soluble gp-130 fused chimera) was used to selectively inhibit IL-6 trans-signaling. IL-6 trans-signaling activation caused a significant increase in STAT3 phosphorylation, expression of adhesion molecules, ROS production and apoptosis in HRECs whereas a significant decrease in mitochondrial membrane potential and NO production was observed in IL-6 trans-signaling activated cells. These changes were not observed in cells pre-treated with sgp130Fc. IL-6 trans-signaling activation was sufficient to cause barrier disruption in endothelial monolayers and pre-treatment of HRECs with sgp130Fc, maintained endothelial barrier function similar to that of untreated cells. Thus, in conclusion, these results indicate that IL-6 trans-signaling is an important mediator of inflammation, apoptosis and barrier disruptive effects in the retinal endothelial cells and inhibition of the IL-6 trans-signaling pathway using sgp130-Fc attenuates vascular inflammation and endothelial barrier disruption.
We also recommend Trading Suppliers and Manufacturers of ALL-TRANS-RETINAL (cas 116-31-4). Pls Click Website Link as below: cas 116-31-4 suppliers
Prev:ALL-TRANS-RETINAL (cas 116-31-4) dimer formation alleviates the cytotoxicity of ALL-TRANS-RETINAL (cas 116-31-4) in human retinal pigment epithelial cells
Next:Isolation of the retinal isomers from the isomerization of ALL-TRANS-RETINAL (cas 116-31-4) by flash countercurrent chromatography☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Endocrine pharmacologyEffects of trans-resveratrol on type 1 diabetes-induced inhibition of retinoic acid metabolism pathway in retinal pigment epithelium of Dark Agouti rats08/31/2019
- Effects of quinones and flavonoids on the reduction of all-trans retinal to all-trans retinol in pig heart08/30/2019
- ArticleA CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration08/29/2019
- ALL-TRANS-RETINAL (cas 116-31-4) induces Bax activation via DNA damage to mediate retinal cell apoptosis08/28/2019
- Research articleAll-trans retinal levels and formation of lipofuscin precursors after bleaching in rod photoreceptors from wild type and Abca4-/- mice08/27/2019
- Neuroprotective effect of tetramethylpyrazine against ALL-TRANS-RETINAL (cas 116-31-4) toxicity in the differentiated Y-79 cells via upregulation of IRBP expression08/26/2019
- Research ArticleInduction of oxidative and nitrosative stresses in human retinal pigment epithelial cells by ALL-TRANS-RETINAL (cas 116-31-4)08/25/2019
- Isolation of the retinal isomers from the isomerization of ALL-TRANS-RETINAL (cas 116-31-4) by flash countercurrent chromatography☆08/24/2019
- ALL-TRANS-RETINAL (cas 116-31-4) dimer formation alleviates the cytotoxicity of ALL-TRANS-RETINAL (cas 116-31-4) in human retinal pigment epithelial cells08/22/2019